CR11761A - PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTAL FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE - Google Patents

PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTAL FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE

Info

Publication number
CR11761A
CR11761A CR11761A CR11761A CR11761A CR 11761 A CR11761 A CR 11761A CR 11761 A CR11761 A CR 11761A CR 11761 A CR11761 A CR 11761A CR 11761 A CR11761 A CR 11761A
Authority
CR
Costa Rica
Prior art keywords
sulfamates
preparation
benzofused
heteroarilo
benzodioxin
Prior art date
Application number
CR11761A
Other languages
Spanish (es)
Inventor
F Abbel-Magid Ahmed
J Mehrman Steven
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR11761A publication Critical patent/CR11761A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

La presente invención se dirige a un proceso para la preparación de sulfamatos de heteroarilo benzofusionados, útiles para el tratamiento de epilepsia y transtonos relacionados.The present invention is directed to a process for the preparation of benzofused heteroaryl sulfamates, useful for the treatment of epilepsy and related transtons.

CR11761A 2008-03-26 2010-10-26 PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTAL FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE CR11761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058233 WO2009120191A1 (en) 2008-03-26 2008-03-26 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide

Publications (1)

Publication Number Publication Date
CR11761A true CR11761A (en) 2011-07-06

Family

ID=40030223

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11761A CR11761A (en) 2008-03-26 2010-10-26 PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTAL FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE

Country Status (14)

Country Link
EP (1) EP2280950A1 (en)
JP (1) JP2011515464A (en)
KR (1) KR20100126535A (en)
CN (1) CN101981019A (en)
AU (1) AU2008353491A1 (en)
BR (1) BRPI0822454A2 (en)
CA (1) CA2719624A1 (en)
CR (1) CR11761A (en)
EA (1) EA201071120A1 (en)
EC (1) ECSP10010499A (en)
IL (1) IL208222A0 (en)
MX (1) MX2010010595A (en)
WO (1) WO2009120191A1 (en)
ZA (1) ZA201007611B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (en) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. Process for preparing sulfamide derivatives
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
EA200870556A1 (en) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. COMBINED THERAPY IN THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
EA018567B1 (en) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CN107954906B (en) * 2017-11-24 2020-10-16 西北师范大学 A kind of synthetic method of arylsulfonyl tertiary amine compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AR049646A1 (en) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv USEFUL SULFAMATE AND SULFAMIDE DERIVATIVES FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DE602005008084D1 (en) * 2004-08-24 2008-08-21 Janssen Pharmaceutica Nv NEW BENZO-CONDENSED HETEROARYLSULFAMID DERIVATIVES SUITABLE AS ANTICONVULSIVE AGENTS
TW200738669A (en) * 2006-02-22 2007-10-16 Janssen Pharmaceutica Nv Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide

Also Published As

Publication number Publication date
IL208222A0 (en) 2010-12-30
EP2280950A1 (en) 2011-02-09
CN101981019A (en) 2011-02-23
MX2010010595A (en) 2010-10-25
WO2009120191A1 (en) 2009-10-01
JP2011515464A (en) 2011-05-19
ECSP10010499A (en) 2010-10-30
CA2719624A1 (en) 2009-10-01
ZA201007611B (en) 2012-04-25
AU2008353491A1 (en) 2009-10-01
KR20100126535A (en) 2010-12-01
BRPI0822454A2 (en) 2015-06-16
EA201071120A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
CR11761A (en) PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTAL FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE
ECSP10010498A (en) PROCESSES FOR THE PREPARATION OF BENZOFUSED HETEROARILO DERIVATIVES
BRPI0821688A2 (en) mixture for the treatment of urea-containing fertilizers
EP2556042A4 (en) INTEGRATED PROCESS FOR THE CONCOMITANT PRODUCTION OF TRANS-1-CHLORO-3,3,3TRIFLUOROPROPENE AND TRANS-1,3,3,3-TETRAFLUOROPROPENE
DOP2012000263A (en) CHEMICAL COMPOUNDS
MX2009005004A (en) Coreotics.
BRPI0923325A2 (en) methods for using a compound, and for suppressing the production of a free isocyanate compound.
MX2010007490A (en) Preparation of sulfamide derivatives.
BR112012004411A2 (en) process for the preparation of hydrogenated nitrile rubber
CL2012001031A1 (en) 2-Oxo-1-pyrrolidinyl-imidazothiadiazole derived compounds; pharmaceutical composition comprising them; useful for the treatment of epilepsy, neurological disorders, among others.
CR20110107A (en) POLYMORPH B OF THE N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] BENZAMIDE (MS-275)
CL2011001405A1 (en) Procedure for the preparation of n- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, agomethalin.
MX340928B (en) Oxazoline and isoxazoline derivatives as crac modulators.
DE112010000867T8 (en) Production method of n-type SiC single crystal, thereby obtained n-type SiC single crystal and its application
CU23820A3 (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND OBTAINING PROCEDURE
EA201200740A1 (en) METHOD OF PYROLYSIS CARBOHYDRATES
BR112013021882A2 (en) synthesis of organic compounds
CL2012003371A1 (en) Intermediate compounds of agomelatine synthesis; and the process for obtaining agomelatine from said intermediary compounds
UY32716A (en) PIRAZINE CARBOXAMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF DIABETES AND OBESITY
EA201170481A1 (en) SKIN CRYSTALS
CR11368A (en) CRYSTAL FORM 1 OF 2- ((R) -2-METHYLPIRROLIDIN-2-IL) -1H-BENZIMIDAZOL-4-CARBOXAMIDA
BRPI0906533A2 (en) "continuous process of oligomerization of isocyanates"
ECSP13012459A (en) HIGHLY CRYSTAL VALSARTAN
GT200900215A (en) NEW PROCEDURE FOR OBTAINING THE CRYSTALLINE V FORM OF AGOMELATINE.
AR058253A1 (en) PROCEDURE FOR THE PREPARATION OF FERRI-SUCCINILCASEINA

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)